Literature DB >> 20039445

Loss of CD103+ intestinal dendritic cells during colonic inflammation.

Ulrike G Strauch1, Nicole Grunwald, Florian Obermeier, Sonja Gürster, Heiko C Rath.   

Abstract

AIM: To investigate possible differences in dendritic cells (DC) within intestinal tissue of mice before and after induction of colitis.
METHODS: Mucosal DC derived from intestinal tissue, as well as from mesenteric lymph nodes and spleen, were analyzed by fluorescence activated cell sorting (FACS) analysis. Supernatants of these cells were analyzed for secretion of different pro- and anti-inflammatory cytokines. Immunohistochemistry and immunofluorescence were performed on cryosections of mucosal tissue derived from animals with colitis as well as from healthy mice.
RESULTS: It was shown that DC derived from healthy intestinal lamina propria (LP) represented an immature phenotype as characterized by low-level expression of costimulatory cytokines. In contrast to DC from spleen and mesenteric lymph nodes (MLN) that secreted proinflammatory cytokines, LP-DC produced high levels of the anti-inflammatory cytokine IL-10. After induction of murine colitis in a CD4(+)CD62L(+) transfer model or in chronic dextran sulfate sodium-colitis, a marked increase of activated CD80(+) DC could be observed within the inflamed colonic tissue. Interestingly, in contrast to splenic DC, a significant population of DC within MLN and colonic LP expressed the mucosal integrin CD103 which was lost during colitis.
CONCLUSION: The constitutive secretion of anti-inflammatory cytokines by immature DC within the intestinal LP might regulate the homeostatic balance between mucosal immunity and tolerance. CD103(+) DC could mediate this important function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20039445      PMCID: PMC2799913          DOI: 10.3748/wjg.v16.i1.21

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  40 in total

1.  Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse.

Authors:  F Anjuère; P Martín; I Ferrero; M L Fraga; G M del Hoyo; N Wright; C Ardavín
Journal:  Blood       Date:  1999-01-15       Impact factor: 22.113

2.  Phenotypic and functional characterization of CD11c+ dendritic cell population in mouse Peyer's patches.

Authors:  C Ruedl; C Rieser; G Böck; G Wick; H Wolf
Journal:  Eur J Immunol       Date:  1996-08       Impact factor: 5.532

3.  Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats.

Authors:  H C Rath; H H Herfarth; J S Ikeda; W B Grenther; T E Hamm; E Balish; J D Taurog; R E Hammer; K H Wilson; R B Sartor
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

4.  Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice.

Authors:  M P Schön; A Arya; E A Murphy; C M Adams; U G Strauch; W W Agace; J Marsal; J P Donohue; H Her; D R Beier; S Olson; L Lefrancois; M B Brenner; M J Grusby; C M Parker
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

5.  IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation.

Authors:  M Schultz; S L Tonkonogy; R K Sellon; C Veltkamp; V L Godfrey; J Kwon; W B Grenther; E Balish; I Horak; R B Sartor
Journal:  Am J Physiol       Date:  1999-06

6.  Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients.

Authors:  R Aranda; B C Sydora; P L McAllister; S W Binder; H Y Yang; S R Targan; M Kronenberg
Journal:  J Immunol       Date:  1997-04-01       Impact factor: 5.422

7.  Characterization of colonic and mesenteric lymph node dendritic cell subpopulations in a murine adoptive transfer model of inflammatory bowel disease.

Authors:  John Karlis; Irmeli Penttila; Tuyet B Tran; Ben Jones; Silvia Nobbs; Heddy Zola; Inge Ea Flesch
Journal:  Inflamm Bowel Dis       Date:  2004-11       Impact factor: 5.325

8.  Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.

Authors:  R K Sellon; S Tonkonogy; M Schultz; L A Dieleman; W Grenther; E Balish; D M Rennick; R B Sartor
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

9.  A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis.

Authors:  H Groux; A O'Garra; M Bigler; M Rouleau; S Antonenko; J E de Vries; M G Roncarolo
Journal:  Nature       Date:  1997-10-16       Impact factor: 49.962

Review 10.  Production of type I interferons: plasmacytoid dendritic cells and beyond.

Authors:  Carine Asselin-Paturel; Giorgio Trinchieri
Journal:  J Exp Med       Date:  2005-08-15       Impact factor: 14.307

View more
  14 in total

1.  IL-10 deficiency blocks the ability of LPS to regulate expression of tolerance-related molecules on dendritic cells.

Authors:  Fang Zhou; Bogoljub Ciric; Hongmei Li; Yaping Yan; Ke Li; Melissa Cullimore; Elisabetta Lauretti; Patricia Gonnella; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Eur J Immunol       Date:  2012-05-23       Impact factor: 5.532

Review 2.  Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease.

Authors:  Sergio Rutella; Franco Locatelli
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

3.  Retinoic acid attenuates ileitis by restoring the balance between T-helper 17 and T regulatory cells.

Authors:  Colm B Collins; Carol M Aherne; Douglas Kominsky; Eóin N McNamee; Matthew D P Lebsack; Holger Eltzschig; Paul Jedlicka; Jesús Rivera-Nieves
Journal:  Gastroenterology       Date:  2011-11       Impact factor: 22.682

4.  Prenatally acquired vitamin A deficiency alters innate immune responses to human rotavirus in a gnotobiotic pig model.

Authors:  Anastasia N Vlasova; Kuldeep S Chattha; Sukumar Kandasamy; Christine S Siegismund; Linda J Saif
Journal:  J Immunol       Date:  2013-03-27       Impact factor: 5.422

5.  IL-4 and retinoic acid synergistically induce regulatory dendritic cells expressing Aldh1a2.

Authors:  Bing Zhu; Thomas Buttrick; Ribal Bassil; Chen Zhu; Marta Olah; Chuan Wu; Sheng Xiao; William Orent; Wassim Elyaman; Samia J Khoury
Journal:  J Immunol       Date:  2013-08-19       Impact factor: 5.422

6.  CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis.

Authors:  Marc-André Wurbel; Severine Le Bras; Mouna Ibourk; Michael Pardo; Maria G McIntire; Dominique Coco; Raif S Geha; Edda Fiebiger; Scott B Snapper
Journal:  Inflamm Bowel Dis       Date:  2014-07       Impact factor: 5.325

7.  Stricture of ileo-anal J pouch anastomosis increased the intensity of pouchitis in an experimental rat model.

Authors:  Tomasz Banasiewicz; Jarosław Walkowiak; Sławomira Drzymała-Czyż; Maciej Borejsza-Wysocki; Przemysław Majewski; Maciej Biczysko; Zoran Stojcev; Karl-Heinz Herzig; Michał Drews
Journal:  Med Sci Monit       Date:  2012-10

8.  Whole-genome microarray analysis and functional characterization reveal distinct gene expression profiles and patterns in two mouse models of ileal inflammation.

Authors:  Leela Rani Avula; Dries Knapen; Roeland Buckinx; Lucia Vergauwen; Dirk Adriaensen; Luc Van Nassauw; Jean-Pierre Timmermans
Journal:  BMC Genomics       Date:  2012-08-06       Impact factor: 3.969

9.  The role of CD103⁺ dendritic cells in the intestinal mucosal immune system.

Authors:  Darren Thomas Ruane; Ed C Lavelle
Journal:  Front Immunol       Date:  2011-07-01       Impact factor: 7.561

10.  Spontaneous colitis in Muc2-deficient mice reflects clinical and cellular features of active ulcerative colitis.

Authors:  Ulf A Wenzel; Maria K Magnusson; Anna Rydström; Caroline Jonstrand; Julia Hengst; Malin E V Johansson; Anna Velcich; Lena Öhman; Hans Strid; Henrik Sjövall; Gunnar C Hansson; Mary Jo Wick
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.